Wealth Enhancement Advisory Services’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.59M Buy
28,195
+8,658
+44% +$1.86M 0.01% 945
2026
Q1
$4.03M Sell
19,537
-7,226
-27% -$1.77M 0.01% 1002
2025
Q4
$6.97M Buy
26,763
+5,095
+24% +$1.28M 0.01% 856
2025
Q3
$5.23M Buy
21,668
+11,175
+106% +$2.67M 0.01% 925
2025
Q2
$2.49M Buy
10,493
+2,415
+30% +$562K ﹤0.01% 1245
2025
Q1
$1.83M Buy
8,078
+801
+11% +$176K ﹤0.01% 1292
2024
Q4
$1.5M Sell
7,277
-428
-6% -$93.9K ﹤0.01% 1320
2024
Q3
$1.87M Buy
7,705
+1,904
+33% +$445K ﹤0.01% 1086
2024
Q2
$1.27M Buy
5,801
+661
+13% +$144K ﹤0.01% 1168
2024
Q1
$1.16M Buy
5,140
+663
+15% +$150K ﹤0.01% 1168
2023
Q4
$984K Sell
4,477
-88
-2% -$18.6K ﹤0.01% 1183
2023
Q3
$1M Buy
+4,565
New +$1.03M ﹤0.01% 1096

Other funds holding STE

Wealth Enhancement Advisory Services's STE Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Steris (STE) stake by 44% in Q2 2026, buying an estimated $1.86M and bringing the position to 28,195 shares worth $5.59M. The position accounts for 0.01% of the portfolio, ranked #945.

Wealth Enhancement Advisory Services first reported a position in STE in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.97M in Q4 2025. 145 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Wealth Enhancement Advisory Services held 28,195 shares of Steris worth $5.59M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 8,658 Steris shares in Q2 2026, an estimated $1.86M.
  • Steris made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #945 holding.
  • Wealth Enhancement Advisory Services first reported a position in Steris in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Steris position peaked at $6.97M in Q4 2025.
  • 145 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.